7
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Austrian National Survey of Prevalence of Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae 1994-96

Pages 345-349 | Published online: 08 Jul 2009

REFERENCES

  • Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77–83.
  • Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC. Susceptibility of 170 penicilin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23–9424 and RP 67829. J Antimicrob Chemother 1997; 31: 273–80.
  • Appelbaum PC. Emerging resistance to antimicrobial agents in gram-positive bacteria. Drugs 1996; 51 (Suppl 1): 1–5.
  • Linares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979–1990). Clin Infect Dis 1992; 15: 99–105.
  • Nava JM, Bella F, Garau J, Lite J, Morera M, Marti C, et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin Infect Dis 1994; 19: 884–90.
  • Marton A, Gulyas M, Munoz R, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163: 542–8.
  • Reichler MR, Rakovsky J, Sobotova A, Slacikova M, Hlavacova B, Hill B, et al. Multiple antimicrobial resistance of pneumococci in children with otitis media, bacteremia, and meningitis in Slovakia. J Infect Dis 1995; 171: 1491–6.
  • Ednie LM, Visalli MA, Jacobs MR, Appelbaum PC. Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneuococci. Antimicrob Agents Chemother 1996; 40: 1950–2.
  • Pankuch GA, Jacobs MR, Appelbaum PC. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 1995; 35: 883–8.
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. NCCLS publication no. M100–S5. Villanova PA: National Committee for Clinical Laboratory Standards, 1995.
  • Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992; 15: 119–27.
  • Geslin P, Buu-Hoi A, Fremaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France 1970–1990. Clin Infect Dis 1992; 15: 95–8.
  • Goldstein FW, Geslin P, Acar JF, the French Study Group. Comparative activity of teicoplanin and vancomycin against 400 penicillin-susceptible and -resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 1994; 13: 33–4.
  • Gür D, Tunckanat F, Sener B, Kanra G, Akalin HE. Penicillin resistance in Streptococcus pneumoniae in Turkey. Eur J Clin Microbiol Infect Dis 1994; 13: 440–1.
  • Kanavaki S, Karabela S, Marinis E, Legakis NJ. Antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Greece. Antimicrob Agents Chemother 1994; 32: 3056–8.
  • Linares J, Alonso T, Perez JL, Ayats J, Dominguez MA, Pallares R. Decreased susceptibility of penicillin-resistant pneumococci to twenty-four β-lactam antibiotics. J Antimicrob Chemother 1992; 30: 279–88.
  • Halls GA. The management of infections and antibiotic therapy: an European survey. J Antimicrob Chemother 1993; 31: 985–1000.
  • Marchese A, Debbia EA, Arvigo A, Pesce A, Schito GC. Susceptibility of Streptococcus pneumoniae strains isolated in Italy to penicillin and ten other antibiotics. J Antimicrob Chemother 1995; 36: 833–7.
  • Wüst J, Huf E, Kayser FH. Antimicrobial susceptibilities and serotypes of invasive Streptococcus pneumoniae strains in Switzerland. J Clin Microbiol 1995; 33: 3159–63.
  • Gross ME, Giron KP, Septimus JD, Mason EO, Musher DM. Antimicrobial activities of beta-lactam antibiotics and gentamicin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob Agents Chemother 1995; 39: 1166–8.
  • Simor AE, Louie M. The Canadian Bacterial Surveillance Network, Low DE.: Canadian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1996; 40: 2190–3.
  • Spangler SK, Jacobs MR, Appelbaum PC. MIC and time-kill studies of antipneumococcal activity of GV 118819X (sanfetrinem) compared with those of other agents. Antimicrob Agents Chemother 1997; 41: 148–55.
  • Breimann RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococci infections in the United States. J Amer Med Assoc 1994; 271: 1831–5.
  • Ednie LM, Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 228 penicillin-and erythromycin-susceptible and -resistant pneumococci to RU 64004, a new ketolide, compared with susceptibilities to 16 other agents. Antimicrob Agents Chemother 1997; 41: 1033–6.
  • Garcia-Leoni ME, Cercenadi E, Rodeno P, Bernaldo-de-Quiros JC, Martinez-Hernandez D, Bouza E. Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis 1992; 14: 427–35.
  • Reinert RR, Queck A, Kaufhold A, Kresken M, Lütticken R. Antimicrobial resistance and type distribution of Streptococcus pneumoniae isolates causing systemic infections in Germany 1992–1994. Clin Infect Dis 1995; 21: 1398–401.
  • Linares J, Alonso T, Ayats J, Alcaide F, Tubau F, Hernandez J, Martin R. In vitro activity of 7 macrolide antibiotics and 9 other antimicrobial agents against penicillin-resistant pneumococci. abstr. 191, p. 130. In Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1991.
  • Mason EO, Kaplan SL, Lamberth LB, Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children’s hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 1992; 36: 1703–7.
  • Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Ped Infect Dis J 1994; 13: 585–9.
  • Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. New Engl J Med 1994; 331: 377–82.
  • Traub WH, Leonhard B. Antibiotic susceptibility of clinical isolates of Streptococcus pneumoniae. Chemother 1996; 42: 240–7.
  • Paris MM, Ramilo O, McCracken GH. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemotherapy 1995; 39: 2171–5.
  • Viladrich PF, Gudiol F, Linares J, Pallares R, Sabate I, Rufi G, Ariza J. Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991; 35: 2467–72.
  • Viladrich PF, Cabellos C, Pallares R, Tubau F, Martinez-Lacasa J, Linares J, Gudiol F. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 218– 20.
  • Hofmann J, Cetron MS, Farley MM, Braughman WS, Facklam RR, Elliott JA, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. New Engl J Med 1995; 333: 481–6.
  • Kiska DL, Kerr A, Jones MC, Chazotte NN, Eskridge B, Miller S, et al. Comparison of antimicrobial susceptibility methods for detection of penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 33: 229–32.
  • Moreillon P, Tomasz A. Penicillin resistance and defective lysis in clinical isolates of pneumococci: evidence for two kinds of antibiotic pressure operating in the clinical environment. J Infect Dis 1988; 157: 1150–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.